GeneMind Biosciences Co., Ltd.
PrivateLast Round
Series D
Sep 14, 2026
Est. Valuation
$573.5M
Total Funding Raised
$307M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
GeneMind Biosciences Co., Ltd. operates in Healthcare & Life Sciences and is based in Shenzhen. Its latest recorded funding round was a Series D round in September 2026.
GeneMind Biosciences Co., Ltd. is a biotechnology company that develops and manufactures DNA sequencing systems and molecular diagnostic technology platforms for clinical and research applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Biotech Equipment, Precision Medicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Usage-Based SaaS, Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GeneMind Biosciences Co., Ltd. Comparables
Compare GeneMind Biosciences Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Salus BioMed | 83% | |
| MGI | 81% | |
| Cygnus Biosciences (Beijing) Co., Ltd. | 81% |
For institutional investors. Book with your work email.
GeneMind Biosciences Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Sep 14, 2026 | ||||
| Series C Extension | May 28, 2025 | ||||
| Series C | Aug 2, 2023 | ||||
| Series B Extension | Sep 15, 2021 | ||||
| Strategic | Jun 21, 2021 | ||||
Series B | Sep 1, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
GeneMind Biosciences Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sincere Capital | Series B |
| Guosheng Hongyuan (Shanghai) Investment Co., Ltd. | Series D |
| Shanghai International Group | Series D |
| Delian Capital | Series D |
| Hunan Provincial Caixin Industrial Fund Management | Series D |
| Shenzhen HTI Group | Series D, Series C |
| Cowin Capital | Series B Extension |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 14, 2026
$89M round led by Shenzhen Capital Group and Shanghai International Group.
- Aug 21, 2026
Monthly visitors increased 35% MoM, reaching 4K.
For institutional investors. Book with your work email.
GeneMind Biosciences Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about GeneMind Biosciences Co., Ltd.'s valuation, stock price, and market status.
Is GeneMind Biosciences Co., Ltd. a public or private company?
GeneMind Biosciences Co., Ltd. is a private company.
What is the current stock price of GeneMind Biosciences Co., Ltd.?
GeneMind Biosciences Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks GeneMind Biosciences Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is GeneMind Biosciences Co., Ltd. worth (valuation)?
GeneMind Biosciences Co., Ltd.'s valuation is estimated at $573.5M based on funding round data.
Can I buy GeneMind Biosciences Co., Ltd. stock?
GeneMind Biosciences Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was GeneMind Biosciences Co., Ltd.'s last funding round?
GeneMind Biosciences Co., Ltd.'s most recent funding round was Series D on September 14, 2026.
Who are the main investors in GeneMind Biosciences Co., Ltd.?
Key investors in GeneMind Biosciences Co., Ltd. include Shanghai International Group, Cowin Capital, Shenzhen Capital Group.
Will GeneMind Biosciences Co., Ltd. IPO soon?
No public IPO plans have been announced for GeneMind Biosciences Co., Ltd..
How can I track GeneMind Biosciences Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in GeneMind Biosciences Co., Ltd.'s shares on secondary markets.